期刊文献+

ACE基因多态性与PTCA合并支架植入术后再狭窄的相关性研究

Relationship between the Polymorphism of Angiotensin I Converting Enzyme Gene and In-stent Restenosis after PTCA with Stent Planting
下载PDF
导出
摘要 目的:探讨血管紧张素Ⅱ转换酶(ACE)基因的多态性与PTCA合并支架植入术后发生支架内再狭窄(ISR)的相关性。方法:选取2001-2003年入我院治疗,成功实施PTCA合并支架植入手术的华东地区冠心病患者共197例,并作为期半年的追踪随访,按照二次冠状动脉造影结果分为术后再狭窄组和未狭窄组,然后运用PCR技术对这197例患者样本进行ACE基因分型,最后采用统计学方法判断ACE基因多态性是否与支架内再狭窄具有相关性。结果:197例患者中再狭窄组为58例,ACE基因型DD、DⅠ、Ⅱ的频率分别为25.9%、39.6%、34.5%;未狭窄组为139例,ACE基因型DD、DⅠ、Ⅱ的频率分别为33.8%、43.9%、22.3%,两组间无显著差异(x2=3.2N).P>0.05)。再狭窄组和未狭窄组的D等位基因的频率分别为52.6%和55.8%,亦无显著差异(x2=3.326.P>0.05)。结论:ACE基因1/D多态性与支架术后再狭窄无相关性。 Objective: To explore the relationship between the polymorphism of angiotensin I converting enzyme gene and the incidence of in-stent restenosis(ISR) after PTCA with stem planting. Methods: In this study we selected 197 coronary artery disease patients living in Eastern China, who underwent successful coronary artery stem placement from 2001 to 2003. All the patients were divided into two groups,the ISR group and the NISR group, based on the results of angiography 6 months later,and their polymorphisms were decided by polymerase chain reaction( PCR). then correlation analysis was done between angiotensin polymorphism and in - stent restenosis. Results: The results of angiography turned out to be 58 ISR samples and 139 NISR samples. According to the PCR results,the ACE gene had three Genotypes(DD.DI,and II ), the frequency of them were 25. 9% .39. 6% ,and 34. 5% respectively in the ISR group,and 33. 8%,43. 9% ,and 22. 3% respectively in the NISR group, no significant discrepancy was show between the two groups(x2 = 3. 250,P>(). 05). The frequency of D alete(52. 6%) in the ISR group was also no significant discrepancy compared to D alete(55. 8%) in the NISR group(x2 = 3. 326,P> 0.05). Conclusion: There was no correlation between the I/D polymorphisms of ACE gene and after stenting restenosis.
出处 《中国临床医学》 北大核心 2005年第3期386-388,共3页 Chinese Journal of Clinical Medicine
基金 国家863高科技项目资助.编号:2002AA326110
  • 相关文献

参考文献17

  • 1樊冰,葛均波,Clemens Von Birgelen,钱菊英,王齐兵,葛雷,陈灏珠.FX miniRAIL球囊成形术治疗冠状动脉支架内再狭窄[J].中国临床医学,2003,10(6):804-807. 被引量:2
  • 2Fran ois B, Bernard K, Rory C, et al. Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta analysis of 16 studies[J].BMJ,2002,325(7):517-519.
  • 3曲秀芬,赵鹃,刘培栋,宋丽芸,赵侃,刘和平,黄永麟.血管紧张素1转换酶基因多态性与支架后再狭窄的相关性研究[J].中华医学杂志,2002,82(7):474-476. 被引量:6
  • 4Rigat B, Hubert C, Alhene-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accouting for half the variance of serum enzyme levels[J]. J Clin Invest, 1990,86(4) : 1343-1346.
  • 5Ohishi M, Fujii K, Minamino T, et al. A potent genetic risk factor for restenosis[J]. Nat Genet. 1993,5(4):324-325.
  • 6Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segrega tion and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels[J]. Am J Hum Genet, 1992,51(1) :197-205.
  • 7Samani NJ, Martin DS, Brack M, et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angnoplasty[J]. Lancet, 1995,345(8956) : 1013-1016.
  • 8Hamon M, Bauters C, Amant C, et al. Relation between the Deletion polymorphism of the angiotensirt-converting enzyme gene and late luminal narrowing after coronary angioplasty[J]. Circulation, 1995,92:296-299.
  • 9Robert YI. Antonio FO, Carlos M, et al. ACE D/I Polymorphism and Incidence of Post-PTCA Restenosis[J]. Hypertension, 2001,37:851-855.
  • 10Koch W, Kastrati A, Mehilli J, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosls after coronary stent placement[J]. Circulation, 2000,102(2) :197-202.

二级参考文献24

  • 1[1]Bauters C, Banos JL, Van Belle E, at al. Six - month angio graphic outcome after successful repeat percutaneous interven tion for in-stent restenosis. Circulation, 1998, 97:318~321.
  • 2[2]Dauerman HL, Baim DS, Cutlip DE, et al. Mechanical debulk ing versus balloon angioplasty for the treatment of diffuse in stent restenosis. AmJ Cardiol, 1998, 82:277~284.
  • 3[3]Teirstein PS, King S. Vascular radiation in a drug- eluting stent world: its not over till it′s over. Circulation, 2003, 108 (4) :384~385.
  • 4[4]Kurbaan AS, Foale RA, Sigwart U. Cutting balloon angioplas ty for in- stent restenosis. Cathet Cardiovasc Intervent, 2000, 50:480~483.
  • 5[5]Ischinger TA, Solar RJ, Hitzke E. Improved outcome with no vel device for low- pressure PTCA in de novo and in- stent le sions. Cardiovasc Radiat Med, 2003, 4(1):2~6.
  • 6[6]Hoffman R, Mintz GS, Mehran R, et al. Intravascular ultra sound predictors of angiographic restenosis in lesions treated with Palmaz- Schatz stents. J Am Coll Cardiol, 1998, 31 :43~ 49.
  • 7[7]Eltchaninoff H, Konning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in - stent restenosis: Immediate results and 6 - month angiographic recurrent restenosis rate. J Am Coll Cardiol, 1998, 32 :980~984.
  • 8[8]Sharma SK, Karakala V, Dangas G, et al. Angiographic pat terns of in - stent restenosis after Palmaz - Schatz stent implan tation and implication on subsequent outcome (Abstr). Eur Heart J,1997, 18:451.
  • 9[9]Mehran R, Mintz GS, Popma J J, et al. Mechanisms and results of balloon angioplasty for the treatment of in- stent restenosis. Am J Cardiol, 1996, 78:618~622.
  • 10[10]Nakamura M, Suzuki T, Matsubara M, et al. Results of cut ting balloon angioplasty for stent restenosis: Japanese Multi center Registry. Circulation, 1998, 31 (Suppl A): 235A.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部